Lipidomic signature of stroke recurrence after transient ischemic attack
Evidence
Sci Rep. 2023 Aug 22;13(1):13706. doi: 10.1038/s41598-023-40838-7.
ABSTRACT
While TIA patients have transient symptoms, they should not be underestimated, as they could have an underlying pathology that may lead to a subsequent stroke: stroke recurrence (SR). Previously, it has been described the involvement of lipids in different vascular diseases. The aim of the current study was to perform a lipidomic analysis to identify differences in the lipidomic profile between patients with SR and patients without. Untargeted lipidomic analysis was performed in plasma samples of 460 consecutive TIA patients recruited < 24 h after the onset of symptoms. 37 (8%) patients suffered SR at 90 days. Lipidomic profiling disclosed 7 lipid species differentially expressed between groups: 5 triacylglycerides (TG), 1 diacylglyceride (DG), and 1 alkenyl-PE (plasmalogen) [specifically, TG(56:1), TG(63:0), TG(58:2), TG(50:5), TG(53:7, DG(38:5)) and PE(P-18:0/18:2)]. 6 of these 7 lipid species belonged to the glycerolipid family and a plasmalogen, pointing to bioenergetics pathways, as well as oxidative stress response. In this context, it was proposed the PE(P-18:0/18:2) as potential biomarker of SR condition.The observed changes in lipid patterns suggest pathophysiological mechanisms associated with lipid droplets metabolism and antioxidant protection that is translated to plasma level as consequence of a more intensive or high-risk ischemic condition related to SR.
J Neurol. 2024 Jul 7. doi: 10.1007/s00415-024-12544-5. Online ahead of print.ABSTRACTINTRODUCTION: Myotonic dystrophy type 1 (DM1) is an autosomal dominant disease characterized by myotonia and...
J Psychiatr Ment Health Nurs. 2024 Jul 7. doi: 10.1111/jpm.13082. Online ahead of print.ABSTRACTINTRODUCTION: Caring for those who have been traumatized can place mental health...
Alzheimers Res Ther. 2024 Jul 5;16(1):152. doi: 10.1186/s13195-024-01501-z.ABSTRACTAlzheimer's Disease (AD) is characterized by structural and functional dysfunction involving the Default Mode Network (DMN), for which...
Alzheimers Res Ther. 2024 Jul 5;16(1):152. doi: 10.1186/s13195-024-01501-z.ABSTRACTAlzheimer's Disease (AD) is characterized by structural and functional dysfunction involving the Default Mode Network (DMN), for which...
Clin Epigenetics. 2024 Jul 5;16(1):88. doi: 10.1186/s13148-024-01697-9.ABSTRACTBACKGROUND: DNA methylation may have a regulatory role in monogenic sensorineural hearing loss and complex, polygenic phenotypic forms of...
Clin Epigenetics. 2024 Jul 5;16(1):88. doi: 10.1186/s13148-024-01697-9.ABSTRACTBACKGROUND: DNA methylation may have a regulatory role in monogenic sensorineural hearing loss and complex, polygenic phenotypic forms of...
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Cookie settingsACCEPT
Privacy & Cookies Policy
Privacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.